Ondansetron (Zofran) is prescribed for which condition in a postoperative client?

Ondansetron (Zofran) is specifically designed to prevent and treat nausea and vomiting, particularly those that can occur after surgical procedures. After surgery, patients may experience postoperative nausea and vomiting (PONV) due to anesthesia, the surgical procedure itself, or other factors related to recovery. Ondansetron works by blocking the actions of chemicals in the body that can trigger this sensation in the brain.

The use of Zofran in postoperative settings is well-supported by clinical practice, as it can significantly improve patient comfort and facilitate a smoother recovery process. Managing these symptoms is crucial because nausea and vomiting can lead to complications such as dehydration, electrolyte imbalance, and delayed recovery. Thus, prescribing Ondansetron for a postoperative client is an appropriate choice to address this common issue.

Other conditions listed, such as paralytic ileus, incisional pain, and urinary retention, require different forms of management and treatment, which do not directly involve medication aimed at controlling nausea and vomiting. Therefore, the focus on Ondansetron as a treatment specifically for nausea and vomiting solidifies its role in postoperative care.